Stay updated on LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Sign up to get notified when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.

Latest updates to the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now renders a 403 Forbidden error page, including a DOCTYPE, a 403 title, and a Home link. This replaces the previous study details with a simple error layout.SummaryDifference20%

- Check39 days agoChange DetectedThe page revision identifier was updated from v3.6.5 to v3.6.6, representing a new release of the page; no specific content changes to the study details are indicated.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page version. This does not modify the study content or its details.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now displays Revision: v3.6.4, indicating a version update. The study content and details remain unchanged.SummaryDifference0.1%

- Check96 days agoChange DetectedA newer revision version (v3.6.3) is displayed, indicating a minor page update without substantive changes to the study details.SummaryDifference0.1%

- Check103 days agoChange DetectedThe revision was updated from v3.6.0 to v3.6.2. This appears to be a minor backend update that does not modify the study details displayed on the page.SummaryDifference0.1%

Stay in the know with updates to LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 Immunotoxin in Pleural Mesotheliomas Clinical Trial page.